Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Sales (2017 - 2021)

Cogent Biosciences has reported Return on Sales over the past 5 years, most recently at 315.41% for Q2 2021.

  • Quarterly results put Return on Sales at 315.41% for Q2 2021, down 30140.0% from a year ago — trailing twelve months through Jun 2021 was 315.41% (down 31444.0% YoY), and the annual figure for FY2025 was 105.07%, changed.
  • Return on Sales for Q2 2021 was 315.41% at Cogent Biosciences, down from 105.52% in the prior quarter.
  • Over the last five years, Return on Sales for COGT hit a ceiling of 0.15% in Q4 2019 and a floor of 315.41% in Q2 2021.
  • Median Return on Sales over the past 5 years was 3.59% (2019), compared with a mean of 37.58%.
  • Biggest five-year swings in Return on Sales: soared 296bps in 2020 and later plummeted -30140bps in 2021.
  • Cogent Biosciences' Return on Sales stood at 3.19% in 2017, then rose by 29bps to 2.26% in 2018, then soared by 107bps to 0.15% in 2019, then plummeted by -7026bps to 10.42% in 2020, then crashed by -2926bps to 315.41% in 2021.
  • The last three reported values for Return on Sales were 315.41% (Q2 2021), 105.52% (Q1 2021), and 10.42% (Q4 2020) per Business Quant data.